HIV-associated wasting in the era of highly active antiretroviral therapy: A syndrome of residual HIV infection in monocytes and macrophages?

Clinical Infectious Diseases

Volumn 40, Issue 12, 2005, Pages 1846-1848

  Shikuma, Cecilia M ^a   Valcour, Victor G ^a   Ratto Kim, Silvia ^a   Williams, Andrew E ^a   Souza, Scott ^a   Gerschenson, Mariana ^a   Day, Larry ^a   Kim, Jerome H ^a   Shiramizu, Bruce ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; BODY WEIGHT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROVIRUS; RETROSPECTIVE STUDY; VIRUS LOAD; WASTING SYNDROME;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; BODY WEIGHT; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; DNA, VIRAL; HIV INFECTIONS; HIV WASTING SYNDROME; HUMANS; MIDDLE AGED; MONOCYTES; RETROSPECTIVE STUDIES; VIRAL LOAD;

EID: 20444381724     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/430376     Document Type: Article

References (12)

1. Smit E, Skolasky RL, Dobs AS, et al. Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection, 1987-1999. Am J Epidemiol 2002; 156:211-8.
2. Wanke CA, Silva M, Knox TA, Forrester J, Speigelman D, Gorbach SL. Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 31:803-5.
3. Roubenoff R, Grinspoon S, Skolnik PR, et al. Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men. Am J Physiol Endocrinol Metab 2002; 283:E138-45.
4. + individuals: the Hawaii Aging with HIV cohort. Neurology 2004; 63:822-7.
5. Shiramizu B, Gartner S, Cho M, et al. Assessment of HIV-1 DNA copies per cell by real-time polymerase chain reaction. Front Biosci 2004; 9:255-61.
6. Silva M, Skolnik PR, Gorbach SL, et al. The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS 1998; 12:1645-51.
7. Shikuma CM, Zackin R, Sattler F, et al. Changes in weight and lean body mass during highly active antiretroviral therapy. Clin Infect Dis 2004; 39:1223-30.
8. Rivera S, Sattler FR, Boyd H, Auffenberg T, Nakao S, Moldawer LL. Urinary cytokines for assessing inflammation in HIV-associated wasting. Cytokine 2001; 13:305-13.
9. Freedman BD, Liu QH, Del Corno M, Collman RG. HIV-1 gp120 chemokine receptor-mediated signaling in human macrophages. Immunol Res 2003; 27:261-76.
10. Belmonte L, Bare P, Picchio GR, et al. Decreased recovery of replication-competent HIV-1 from peripheral blood mononuclear cell-derived monocyte/macrophages of HIV-positive patients after 3 years on highly active antiretroviral therapy. AIDS 2002; 16:1289-92.
11. Aquaro S, Calio R, Balzarini J, Bellocchi MC, Garaci E, Perno CF. Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir. Antiviral Res 2002; 55:209-25.
12. Grinspoon S, Mulligan K. Weight loss and wasting in patients infected with human immunodeficiency virus. Clin Infect Dis 2003; 36:569-78.